Latest Business Development News

Metgasco has secured shareholder approval to sell its 25% interests in the Odin and Vali gas fields for $5.9 million, marking a strategic exit from its core assets amid declining production and ongoing liquidity challenges.

ACDC Metals has reported encouraging mineralogy results from its Goschen Central Rare Earth Elements project, reinforcing its strategic value amid rising geopolitical interest. The company maintains a solid cash balance to support ongoing development and exploration activities.

Estrella Resources has reported multiple high-grade manganese intersections at its Ira Miri project, including assays up to 58% manganese, and received regulatory approval for a 30,000-tonne bulk sample extraction. Concurrently, drilling at the Werumata limestone project has been completed with assay results pending.

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.

Neurizon Therapeutics has cleared a major regulatory hurdle with the FDA lifting the clinical hold on its lead drug NUZ-001 and secured a comprehensive $33 million funding package to advance its pivotal ALS trial.

Synertec Corporation Limited has reported a robust 25% increase in revenue for FY26 Q2 alongside a significant turnaround to positive operating cashflow, underpinned by strong project pipelines and strategic partnerships.

LCL Resources reported promising high-grade gold-copper-silver assays from trenching in Papua New Guinea and is actively pursuing lower-risk jurisdiction assets while advancing its Colombian option agreement.

Sierra Nevada Gold (ASX – SNX) has won the bid for the expansive As Safra Copper-Gold Project in Saudi Arabia, marking a major step in its global exploration strategy. Concurrently, drilling progresses at its Nevada Warrior Gold Project with results anticipated soon.

ARC Funds Limited reported a solid $530 million in funds under management for its Term Deposit Shop platform, while strategically selling Ausbiz TV convertible notes and completing a $738,000 capital raise to bolster its balance sheet and fuel growth.

Bio-Gene Technology Limited reports strong progress in advancing its Flavocide® and Qcide® insecticidal platforms, backed by US Department of Defense funding and key organic certification in the US.

Middle Island Resources has completed a strategic acquisition in Serbia, backed by a $3.4 million capital raise, and reported promising high-grade drilling results at its Bobija Project, signalling a significant step forward in its exploration ambitions.

Stelar Metals is actively expanding its project portfolio in Tier 1 jurisdictions while reassessing past assay results to capitalise on recent commodity price gains. The company also navigates leadership changes and Native Title negotiations as it prepares for a pivotal March update.